Home Multimedia Podcasts NOVEL APPROACH TO CANCER DRUG DEVELOPMENT NOVEL APPROACH TO CANCER DRUG DEVELOPMENT May 22, 2008 – Interview with Ronen Marmorstein, Ph.D., Professor, Gene Expression and Regulation Program, Wistar Institute PodcastsResourcesBiomoleculesCancer drug discoveryCancersCellular, Molecular and Developmental BiologyDrug development (Research and development)Drug discoveryDrug research and developmentEnzymesMedicine, Diagnosis, and TherapeuticsMelanomaPharmacologyResearch and developmentSkin cancerSystemic conditions Also of Interest New High-Throughput, AI-Based, Protein Prediction Method May Advance Drug Discovery Novel Target for Alzheimer's Disease Identified HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody Novo Nordisk to Acquire Cardior for Up to $1.1B, Boosting Cardiovascular Pipeline Drug-Resistant Bacteria Stymied by AI-Designed Antibiotics Related Media Sun, Spatial, and Sequencing: A Video Report from the First Day of AGBT What’s in Store for 2024? Three CEOs Look Ahead and Look Back on “Close to the Edge” Excitement in Oakland: A Report from SynBioBeta BIO CEO Rachel King Outlines Industry's Challenges on "Close to the Edge" Carl Icahn States His Case for Change at Illumina on "Close to the Edge" Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Related Content New High-Throughput, AI-Based, Protein Prediction Method May Advance Drug Discovery Novel Target for Alzheimer’s Disease Identified HIV-Free Hopes Raised by Reservoir-Targeting VLPs Rising from the Ashes: FDA Grants EUA to Invivyd COVID-19 Antibody